Department of Cardiac Surgery, Boston Children's Hospital, Boston, Massachusetts, USA; Department of Surgery, Harvard Medical School, Boston, Massachusetts, USA.
Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
J Am Coll Cardiol. 2021 May 18;77(19):2382-2394. doi: 10.1016/j.jacc.2021.03.304.
Many factors affect outcomes after congenital cardiac surgery.
The RLS (Residual Lesion Score) study explored the impact of severity of residual lesions on post-operative outcomes across operations of varying complexity.
In a prospective, multicenter, observational study, 17 sites enrolled 1,149 infants undergoing 5 common operations: tetralogy of Fallot repair (n = 250), complete atrioventricular septal defect repair (n = 249), arterial switch operation (n = 251), coarctation or interrupted arch with ventricular septal defect (VSD) repair (n = 150), and Norwood operation (n = 249). The RLS was assigned based on post-operative echocardiography and clinical events: RLS 1 (trivial or no residual lesions), RLS 2 (minor residual lesions), or RLS 3 (reintervention for or major residual lesions before discharge). The primary outcome was days alive and out of hospital within 30 post-operative days (60 for Norwood). Secondary outcomes assessed post-operative course, including major medical events and days in hospital.
RLS 3 (vs. RLS 1) was an independent risk factor for fewer days alive and out of hospital (p ≤ 0.008) and longer post-operative hospital stay (p ≤ 0.02) for all 5 operations, and for all secondary outcomes after coarctation or interrupted arch with VSD repair and Norwood (p ≤ 0.03). Outcomes for RLS 1 versus 2 did not differ consistently. RLS alone explained 5% (tetralogy of Fallot repair) to 20% (Norwood) of variation in the primary outcome.
Adjusting for pre-operative factors, residual lesions after congenital cardiac surgery impacted in-hospital outcomes across operative complexity with greatest impact following complex operations. Minor residual lesions had minimal impact. These findings may provide guidance for surgeons when considering short-term risks and benefits of returning to bypass to repair residual lesions.
许多因素会影响先天性心脏病手术后的结果。
RLS(残余病变评分)研究探讨了残余病变严重程度对不同复杂程度手术术后结果的影响。
在一项前瞻性、多中心、观察性研究中,17 个地点招募了 1149 名接受 5 种常见手术的婴儿:法洛四联症修复术(n=250)、完全房室间隔缺损修复术(n=249)、动脉调转术(n=251)、矫正型大动脉转位或室间隔缺损合并主动脉弓中断修复术(n=150)和 Norwood 手术(n=249)。根据术后超声心动图和临床事件分配 RLS:RLS 1(轻微或无残余病变)、RLS 2(轻度残余病变)或 RLS 3(出院前因残余病变再次干预或严重残余病变)。主要结局为术后 30 天(Norwood 为 60 天)内存活且不在医院的天数。次要结局评估术后过程,包括重大医疗事件和住院天数。
与 RLS 1 相比(vs. RLS 1),RLS 3 是所有 5 种手术存活且不在医院天数减少(p≤0.008)和术后住院时间延长(p≤0.02)的独立危险因素,以及矫正型大动脉转位或室间隔缺损合并主动脉弓中断修复术和 Norwood 术后所有次要结局(p≤0.03)的危险因素。RLS 1 与 2 之间的结果不一致。RLS 单独解释了主要结局 5%(法洛四联症修复术)至 20%(Norwood 手术)的变异性。
调整术前因素后,先天性心脏病手术后的残余病变影响了手术复杂程度的住院结果,对复杂手术的影响最大。轻度残余病变影响最小。这些发现可能为外科医生在考虑返回旁路修复残余病变的短期风险和收益时提供指导。